Chlorpromazine Hydrochloride Tablet
Product Images NDC 59651-571

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Chlorpromazine Hydrochloride (NDC 59651-571). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label.principal Display Panel- 10 mg (100 Tablet Bottle) (Chlorpromazine Fig1)

Package Label.principal Display Panel- 10 mg (100 Tablet Bottle) (Chlorpromazine Fig1)
Each tablet of NDC 59651-567-01 contains 10 mg of Chlorpromazine hydrochloride, USP by Aurobindo Pharma USA, Inc. The usual dosage information is available through prescribing. The tablets are made in India and should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C. It is important to protect the medication from light and moisture. This package is not for household dispensing and should be kept away from children. The tablets are sealed for protection in a well-closed, light-resistant, child-resistant container.*
FDA Label Image

Package Label-principal Display Panel (25 mg (100 Tablet Bottle))

Package Label-principal Display Panel (25 mg (100 Tablet Bottle))
This text provides information about a medication labeled as NDC 59651-568-01, which is Chlorpromazine Hydrochloride tablets containing 25 mg of the active ingredient. The medication is distributed by Aurobindo Pharma USA, Inc. The usual dosage and prescription information should be followed. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C. It is noted that the medication is made in India. The packaging should be protected from light and moisture and stored in a controlled room temperature as per USP guidelines. The tablets should be kept in a well-closed, light-resistant, child-resistant container and out of reach of children. Aurobindo Pharma provides a package of 100 tablets sealed for the patient's protection.*
FDA Label Image

Package Label-principal Display Panel (50 mg (100 Tablet Bottle))

Package Label-principal Display Panel (50 mg (100 Tablet Bottle))
The text specifies information about a tablet containing Chlorpromazine hydrochloride (50 mg) by Aurobindo Pharma USA, Inc. The recommended storage temperature ranges from 20°C to 25°C, with excursions permitted between 15°C and 30°C. The medication should be protected from light and moisture. It is suggested to store the tablets in a well-closed, light-resistant, child-resistant container. The dosage regimen should follow the prescribing information provided. The product is manufactured in India and is for prescription use only.*
FDA Label Image

Package Label-principal Display Panel (100 mg (100 Tablet Bottle))

Package Label-principal Display Panel (100 mg (100 Tablet Bottle))
This is information about chlorpromazine hydrochloride tablets. The tablets contain 100 mg of chlorpromazine hydrochloride, and are intended for use only in severe neuropsychiatric conditions. The typical dosage should be determined based on prescribing information. The tablets should be stored at 20° to 25°C (68° to 77°F) with excursions allowed to 15° to 30°C (59° to 86°F). It is important to protect them from light and moisture. This medication is not for household dispensing. If issued for outpatient use, a well-closed, light-resistant, child-resistant container should be used. The tablets should be kept out of reach of children. The product is distributed by Aurobindo Pharma USA, Inc., with the manufacturing done in India.*
FDA Label Image

Package Label-principal Display Panel (200 mg (100 Tablet Bottle))

Package Label-principal Display Panel (200 mg (100 Tablet Bottle))
This is a prescription medication with the active ingredient Chlorpromazine Hydrochloride. Each tablet contains 200 mg of the active ingredient and is intended for use in severe neuropsychiatric conditions. The usual dosage should be followed as per Prescribing Information. The tablets should be stored at 20° to 25°C (68° to 77°F) and protected from light and moisture. This medication should be kept out of reach of children. It is manufactured in India and distributed by Aurobindo Pharma USA, Inc.*
FDA Label Image

Str (Chlorpromazine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.